Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

After images: Difference between revisions

From PsychonautWiki Archive
Jump to navigation Jump to search
← Older editNewer edit →
>Graham
Reference
>Unity
Undo revision 123586 by Graham (talk) Removed nonspecific citation
Line 1: Line 1:
<onlyinclude>
<onlyinclude>
{{#ev:gfycat|https://giant.gfycat.com/PepperyMedicalAfghanhound.webm|400x225|right|'''After images''' by '''[https://www.reddit.com/user/StingrayZ StingrayZ]''' - This image serves as an accurate portrayal of the commonly experienced [[psychedelic]] effect known as after images. There is also a significant amount of [[drifting|visual drifting]] within its background.|frame}}
{{#ev:gfycat|https://giant.gfycat.com/PepperyMedicalAfghanhound.webm|400x225|right|'''After images''' by '''[https://www.reddit.com/user/StingrayZ StingrayZ]''' - This image serves as an accurate portrayal of the commonly experienced [[psychedelic]] effect known as after images. There is also a significant amount of [[drifting|visual drifting]] within its background.|frame}}
'''After images''' are a visual distortion<ref name="Juszczak2013">Juszczak, G. R., & Swiergiel, A. H. (2013). Recreational use of D-lysergamide from the seeds of Argyreia nervosa, Ipomoea tricolor, Ipomoea violacea, and Ipomoea purpurea in Poland. Journal of psychoactive drugs, 45(1), 79-93. https://doi.org/10.1080/02791072.2013.763570</ref> that can be described as an image continuing to appear in one's vision after exposure to the original image has ceased.<ref>Kawasaki, A., & Purvin, V. (1996). Persistent palinopsia following ingestion of lysergic acid diethylamide (LSD). Archives of Ophthalmology, 114(1), 47-50. https://doi.org/10.1001/archopht.1996.01100130045007</ref><ref name="Visual_Function_1988">Abraham, H. D., & Wolf, E. (1988). Visual function in past users of LSD: Psychophysical findings. Journal of Abnormal Psychology, 97(4), 443. http://psycnet.apa.org/doi/10.1037/0021-843X.97.4.443</ref><ref>Abraham HD. Hallucinogen-related disorders. In: Sadock BJ,
'''After images''' are a visual distortion that can be described as an image continuing to appear in one's vision after exposure to the original image has ceased.<ref>Kawasaki, A., & Purvin, V. (1996). Persistent palinopsia following ingestion of lysergic acid diethylamide (LSD). Archives of Ophthalmology, 114(1), 47-50. https://doi.org/10.1001/archopht.1996.01100130045007</ref><ref name="Visual_Function_1988">Abraham, H. D., & Wolf, E. (1988). Visual function in past users of LSD: Psychophysical findings. Journal of Abnormal Psychology, 97(4), 443. http://psycnet.apa.org/doi/10.1037/0021-843X.97.4.443</ref><ref>Abraham HD. Hallucinogen-related disorders. In: Sadock BJ,
Sadock VA, eds. Kaplan and Sadock’s comprehensive textbook
Sadock VA, eds. Kaplan and Sadock’s comprehensive textbook
of psychiatry, seventh edition. Philadelphia: Lippincott, Williams,
of psychiatry, seventh edition. Philadelphia: Lippincott, Williams,
Line 8: Line 8:
During [[hallucinogen|hallucinogenic]] experiences, still overlayed images of moving objects are commonly left in place of where the object once was.<ref name="VisualPhen"/><ref name="VisualTrails">Dubois, J., & VanRullen, R. (2011). Visual trails: do the doors of perception open periodically?. PLoS biology, 9(5), e1001056. https://dx.doi.org/10.1371%2Fjournal.pbio.1001056</ref><ref name="Trifluoperazine">Anderson, W. H., & O'Malley, J. E. (1972). Trifluoperazine for the trailing phenomenon. JAMA, 220(9), 1244-1245. https://doi.org/10.1001/jama.1972.03200090066017</ref><ref name="Topiramate">Fontenelle, L. F. (2008). Topiramate-induced palinopsia. The Journal of neuropsychiatry and clinical neurosciences, 20(2), 249-250. https://doi.org/10.1176/jnp.2008.20.2.249</ref><ref name="Nefazodone">Horton, J. C., & Trobe, J. D. (1999). Akinetopsia from nefazodone toxicity. American journal of ophthalmology, 128(4), 530-531. https://doi.org/10.1016/S0002-9394(99)00177-4</ref><ref>Ermentrout B. The excited cortex - LSD trails, phosphenes, and other visual confections. 1999. 201 Eighth Annual Computational Neuroscience Meeting; Pittsburgh, Pennsylvania; July 1999. Abstracts.</ref> This creates a series of overlayed images across one's visual field which become less distinct the further away they are from the moving object's current position. Another manifestation of this effect can be described as being able to see the external environment for several seconds after one closes their eyes before it gradually fades away.
During [[hallucinogen|hallucinogenic]] experiences, still overlayed images of moving objects are commonly left in place of where the object once was.<ref name="VisualPhen"/><ref name="VisualTrails">Dubois, J., & VanRullen, R. (2011). Visual trails: do the doors of perception open periodically?. PLoS biology, 9(5), e1001056. https://dx.doi.org/10.1371%2Fjournal.pbio.1001056</ref><ref name="Trifluoperazine">Anderson, W. H., & O'Malley, J. E. (1972). Trifluoperazine for the trailing phenomenon. JAMA, 220(9), 1244-1245. https://doi.org/10.1001/jama.1972.03200090066017</ref><ref name="Topiramate">Fontenelle, L. F. (2008). Topiramate-induced palinopsia. The Journal of neuropsychiatry and clinical neurosciences, 20(2), 249-250. https://doi.org/10.1176/jnp.2008.20.2.249</ref><ref name="Nefazodone">Horton, J. C., & Trobe, J. D. (1999). Akinetopsia from nefazodone toxicity. American journal of ophthalmology, 128(4), 530-531. https://doi.org/10.1016/S0002-9394(99)00177-4</ref><ref>Ermentrout B. The excited cortex - LSD trails, phosphenes, and other visual confections. 1999. 201 Eighth Annual Computational Neuroscience Meeting; Pittsburgh, Pennsylvania; July 1999. Abstracts.</ref> This creates a series of overlayed images across one's visual field which become less distinct the further away they are from the moving object's current position. Another manifestation of this effect can be described as being able to see the external environment for several seconds after one closes their eyes before it gradually fades away.


After images are often accompanied by other coinciding effects such as [[tracers]]<ref name="Visual_Function_1988"/><ref name="Psych2002"/><ref name="VisualPhen"/><ref name="Trifluoperazine"/><ref>Asher, H. (1971). Trailing” phenomenon–a long-lasting LSD side effect. Am J Psychiatry, 127(9), 1233-4. https://doi.org/10.1176/ajp.127.9.1233</ref><ref>Schwartz, K. (1997). Nefazodone and visual side effects. The American journal of psychiatry, 154(7), 1038. https://www.ncbi.nlm.nih.gov/pubmed/9210763</ref> and [[drifting]].<ref name="25B"/> They are most commonly induced under the influence of [[dosage#common|moderate]] [[dosage|dosages]] of [[psychedelic]] compounds, such as [[LSD]],<ref name="Juszczak2013"/> [[psilocybin]], and [[mescaline]].<ref name="Psych2002"/><ref name="Topiramate"/><ref name="Nefazodone"/><ref>Halberstadt, A. L. (2015). Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Behavioural brain research, 277, 99-120. https://dx.doi.org/10.1016%2Fj.bbr.2014.07.016</ref></onlyinclude><ref>Lauterbach, E., Abdelhamid, A., & Annandale, J. B. (2000). Posthallucinogen-like visual illusions (palinopsia) with risperidone in a patient without previous hallucinogen exposure: possible relation to serotonin 5HT2a receptor blockade. Pharmacopsychiatry, 33(01), 38-41.https://doi.org/10.1055/s-2000-8452</ref> However, trailing effects have also been experienced with other drugs of a very different pharmacology, such as GABA potentiators.<ref name="VisualTrails"/><ref name="Topiramate"/>
After images are often accompanied by other coinciding effects such as [[tracers]]<ref name="Visual_Function_1988"/><ref name="Psych2002"/><ref name="VisualPhen"/><ref name="Trifluoperazine"/><ref>Asher, H. (1971). Trailing” phenomenon–a long-lasting LSD side effect. Am J Psychiatry, 127(9), 1233-4. https://doi.org/10.1176/ajp.127.9.1233</ref><ref>Schwartz, K. (1997). Nefazodone and visual side effects. The American journal of psychiatry, 154(7), 1038. https://www.ncbi.nlm.nih.gov/pubmed/9210763</ref> and [[drifting]].<ref name="25B"/> They are most commonly induced under the influence of [[dosage#common|moderate]] [[dosage|dosages]] of [[psychedelic]] compounds, such as [[LSD]], [[psilocybin]], and [[mescaline]].<ref name="Psych2002"/><ref name="Topiramate"/><ref name="Nefazodone"/><ref>Halberstadt, A. L. (2015). Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Behavioural brain research, 277, 99-120. https://dx.doi.org/10.1016%2Fj.bbr.2014.07.016</ref></onlyinclude><ref>Lauterbach, E., Abdelhamid, A., & Annandale, J. B. (2000). Posthallucinogen-like visual illusions (palinopsia) with risperidone in a patient without previous hallucinogen exposure: possible relation to serotonin 5HT2a receptor blockade. Pharmacopsychiatry, 33(01), 38-41.https://doi.org/10.1055/s-2000-8452</ref> However, trailing effects have also been experienced with other drugs of a very different pharmacology, such as GABA potentiators.<ref name="VisualTrails"/><ref name="Topiramate"/>
===Psychoactive substances===
===Psychoactive substances===
Compounds within our [[psychoactive substance index]] which may cause this effect include:
Compounds within our [[psychoactive substance index]] which may cause this effect include:

Revision as of 16:24, 28 March 2018

{{#ev:gfycat|https://giant.gfycat.com/PepperyMedicalAfghanhound.webm%7C400x225%7Cright%7CAfter images by StingrayZ - This image serves as an accurate portrayal of the commonly experienced psychedelic effect known as after images. There is also a significant amount of visual drifting within its background.|frame}} After images are a visual distortion that can be described as an image continuing to appear in one's vision after exposure to the original image has ceased.[1][2][3][4][5][6][7][8][9][10][11] A common form of after image is the bright glow that seems to float in one's vision after looking into a light source for a few seconds. This effect is similar to tracers, but differs in that it does not create smooth blurs behind moving objects.

During hallucinogenic experiences, still overlayed images of moving objects are commonly left in place of where the object once was.[9][12][13][14][15][16] This creates a series of overlayed images across one's visual field which become less distinct the further away they are from the moving object's current position. Another manifestation of this effect can be described as being able to see the external environment for several seconds after one closes their eyes before it gradually fades away.

After images are often accompanied by other coinciding effects such as tracers[2][4][9][13][17][18] and drifting.[8] They are most commonly induced under the influence of moderate dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline.[4][14][15][19][20] However, trailing effects have also been experienced with other drugs of a very different pharmacology, such as GABA potentiators.[12][14]

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Anecdotal reports which describe this effect within our experience index include:

See also

References

  1. ↑ Kawasaki, A., & Purvin, V. (1996). Persistent palinopsia following ingestion of lysergic acid diethylamide (LSD). Archives of Ophthalmology, 114(1), 47-50. https://doi.org/10.1001/archopht.1996.01100130045007
  2. ↑ 2.0 2.1 Abraham, H. D., & Wolf, E. (1988). Visual function in past users of LSD: Psychophysical findings. Journal of Abnormal Psychology, 97(4), 443. http://psycnet.apa.org/doi/10.1037/0021-843X.97.4.443
  3. ↑ Abraham HD. Hallucinogen-related disorders. In: Sadock BJ, Sadock VA, eds. Kaplan and Sadock’s comprehensive textbook of psychiatry, seventh edition. Philadelphia: Lippincott, Williams, & Wilkins, 2000:1015–1024.
  4. ↑ 4.0 4.1 4.2 Abraham, H. D., Mccann, U. D., & Ricaurte, G. A. (2002). Psychedelic drugs. http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.623.299
  5. ↑ Bressloff, P. C., Cowan, J. D., Golubitsky, M., Thomas, P. J., & Wiener, M. C. (2001). Geometric visual hallucinations, Euclidean symmetry and the functional architecture of striate cortex. Philosophical Transactions of the Royal Society of London B: Biological Sciences, 356(1407), 300. https://doi.org/10.1098/rstb.2000.0769
  6. ↑ Kluver, H. 1966 Mescal and mechanisms and hallucinations. University of Chicago Press.
  7. ↑ Kleinman, J. E., Gillin, J. C., & Wyatt, R. J. (1977). A comparison of the phenomenology of hallucinogens and schizophrenia from some autobiographical accounts. Schizophrenia Bulletin, 3(4), 562. https://dx.doi.org/10.1093/schbul/3.4.560
  8. ↑ 8.0 8.1 Papoutsis, I., Nikolaou, P., Stefanidou, M., Spiliopoulou, C., & Athanaselis, S. (2015). 25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers. Forensic Toxicology, 33(1), 1-11. https://doi.org/10.1007/s11419-014-0242-9
  9. ↑ 9.0 9.1 9.2 Abraham, H. D. (1983). Visual phenomenology of the LSD flashback. Arch Gen Psychiatry, 40(8), 886-887. https://jamanetwork.com/journals/jamapsychiatry/article-abstract/493119
  10. ↑ Kraus, R. P. (1996). Visual" trails" with nefazodone treatment. The American journal of psychiatry, 153(10), 1365. https://www.ncbi.nlm.nih.gov/pubmed/8831452
  11. ↑ Sunness, J. S. (2004). Persistent afterimages (palinopsia) and photophobia in a patient with a history of LSD use. Retina, 24(5), 805. https://www.ncbi.nlm.nih.gov/pubmed/15492641
  12. ↑ 12.0 12.1 Dubois, J., & VanRullen, R. (2011). Visual trails: do the doors of perception open periodically?. PLoS biology, 9(5), e1001056. https://dx.doi.org/10.1371%2Fjournal.pbio.1001056
  13. ↑ 13.0 13.1 Anderson, W. H., & O'Malley, J. E. (1972). Trifluoperazine for the trailing phenomenon. JAMA, 220(9), 1244-1245. https://doi.org/10.1001/jama.1972.03200090066017
  14. ↑ 14.0 14.1 14.2 Fontenelle, L. F. (2008). Topiramate-induced palinopsia. The Journal of neuropsychiatry and clinical neurosciences, 20(2), 249-250. https://doi.org/10.1176/jnp.2008.20.2.249
  15. ↑ 15.0 15.1 Horton, J. C., & Trobe, J. D. (1999). Akinetopsia from nefazodone toxicity. American journal of ophthalmology, 128(4), 530-531. https://doi.org/10.1016/S0002-9394(99)00177-4
  16. ↑ Ermentrout B. The excited cortex - LSD trails, phosphenes, and other visual confections. 1999. 201 Eighth Annual Computational Neuroscience Meeting; Pittsburgh, Pennsylvania; July 1999. Abstracts.
  17. ↑ Asher, H. (1971). Trailing” phenomenon–a long-lasting LSD side effect. Am J Psychiatry, 127(9), 1233-4. https://doi.org/10.1176/ajp.127.9.1233
  18. ↑ Schwartz, K. (1997). Nefazodone and visual side effects. The American journal of psychiatry, 154(7), 1038. https://www.ncbi.nlm.nih.gov/pubmed/9210763
  19. ↑ Halberstadt, A. L. (2015). Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Behavioural brain research, 277, 99-120. https://dx.doi.org/10.1016%2Fj.bbr.2014.07.016
  20. ↑ Lauterbach, E., Abdelhamid, A., & Annandale, J. B. (2000). Posthallucinogen-like visual illusions (palinopsia) with risperidone in a patient without previous hallucinogen exposure: possible relation to serotonin 5HT2a receptor blockade. Pharmacopsychiatry, 33(01), 38-41.https://doi.org/10.1055/s-2000-8452
Retrieved from "http://psy.st/w/index.php?title=After_images&oldid=102344"